Background: Despite the availability of an effective vaccine for more than three decades, HBV (hepatitis B virus) continues to infect many people worldwide, particularly in developing countries of Asia. In older people at higher risk of infection, high prevalence of HBV may exist, particularly among intravenous drug users (IDUs). This group is among groups at higher risk of infection as they share needles for drug injection. Objectives: The current study aimed to determine the prevalence of HBsAg (hepatitis B antigen) among intravenous drug users in dropin-centers (DICs) of Tehran in 2013. Patients and Methods: This cross sectional study included 129 intravenous drug users recruited from DICs in Tehran in 2013. Sociodemographic characteristics and associated risk factors were recorded during the sample collection. Their serum samples were tested for the presence of HBsAg by enzyme-linked immunosorbent assay (ELISA). Results: HBsAg was detected in 4 of 129 subjects, giving an overall prevalence of 3.1%. No significant correlation was observed between HBsAg positivity and socio-demographic and associated risk factors. Conclusions: Undoubtedly, IDUs are one of the most high-risk groups exposed to infection; so the priority of preventive and educational programs would be beneficial for this high-risk group. Screening IDUs at the national level and statistical analysis for HBV in the larger sample size is recommended.
Background
Intravenous drug users (IDUs) are at increased risk for acquiring blood-borne infectious diseases, particularly hepatitis B virus (HBV) (1) . Hazardous behaviors of these addicts such as sharing syringes, using the same syringe several times, or using infected syringes are the main routes for infection with human immunodeficiency virus (HIV), hepatitis B, C and various lung and cerebral abscesses. Infection with these types of diseases at family and society levels can be the result of sexual hazardous behaviors of this infected group (2) . To the best of our knowledge, up to 90% of DIUs suffer from one of the viral diseases. There is a direct relationship between the number of cases infected by these viruses and duration of injection drug usage (3) . Long duration of drug injection may lead to more sharing of needles and other instruments, resulting in a greater likelihood of transmission (4) .
Other studies demonstrated that long-term imprisonment, with drug injection behavior is independently associated with HBV infection (5, 6) . Incorporation of routine HBV screening, vaccination, long-term treatment, improved jail health system, detoxification clinics and harm reduction programs like DICs, are among important steps to reduce further transmission and the future burden of blood-borne diseases (7) . Iran has one of the highest per capita number of opioid users in the world, with a substantial and potentially growing population of IDUs (8) . According to a report by the Iranian welfare organization, among 1.8 million drug users in Iran, 9% to 16% are IDUs, while half of them share needles. It could be estimated that the IDU population in Iran ranges between 200000 and 300000 IDUs. As the number of IDUs is increasing in Iran, there could be potential danger for the national health system (9) .
Injection drug usage has been the most major route of drug abuse in Iran during the past decade (3) . In this regard, the high rates of HCV and HBV infection among IDUs have been reported in Iran (10) (11) (12) . The reports showed controversial results about the association between injecting drug behavior and the high rate of HBV & HCV (13) (14) (15) (16) . In 2002, a harm reduction policy was adopted in Iran; expansion of harm reduction policy started after the design of the national five-year program (2002) (2003) (2004) (2005) (2006) (2007) . Around 1400000 needles and syringes were distributed to IDUs through 120 DICs, over a six-month period in 2007 (17) . Another program was opioid substitution treatment among 22000 drug users in mid-2007 (17) . Educational programs on hepatitis B risk factors, increasing easy and affordable access to HBV-testing and free vaccination for IDUs are important to reduce the prevalence of HBV infection in this group (18) .
Objectives
This study examined the characteristics, risk behaviors and risk factors of HBV infection among IDUs in Tehran. The results of this study were associated with the prevalence of HBsAg and the correlating factors in this group, and services provided for IDUs in DICs such as needle and syringe program (NSP) in Tehran.
Patients and Methods

Sample Selection and Study Population
A cross-sectional study was performed on 129 volunteers (128 males and 1 female), current IDUs selected from three DICs located in different well-known areas with high rates of drug-related risk behaviors between April and June 2013 in Tehran. Face-to-face interviews were done using questionnaires that elicited personal data containing demographic data such as age, gender, employment status, marital status, history and duration of addiction, history of imprisonment, kind and route of drug use, hepatitis B vaccination, and some high-risk behaviors like sharing syringes, sexual behaviors and tattooing. Five milliliter peripheral blood was taken from each individual and transported to the laboratory for storage. IDUs were able to receive the results of their tests based on their own code number.
Detection of Serology Markers
Sera were collected and stored in aliquots at -20 °C for further testing. The samples were examined using enzyme-linked immunosorbent assay (ELISA) to detect HBsAg. HBsAg was checked using highly specific enzyme immune assays (DIA. Pro, ITALY, specificity > 99%). All positive samples for HBsAg were tested twice using the same method to confirm the results.
Statistical Analysis
Data were extracted from questionnaires, and summarized. The standard Chi-square test was used to assess the correlation of demographic and behavioral variables and HBsAg positivity. All analyses were performed using SPSS for windows (version 19: SPSS Inc, USA). Results were regarded as significant when P < 0.05.
Results
A total of 129 IDUs participated in this study; note that some of them were DIC workers who had a history of injection drug usage. Regarding the age of the participants, 17.1% of subjects were between 20-30 years old, 34.1% were between 30-40, 29.5% were between 40-50 and the rest were above 50 years old (Table 1) .
Socio-demographic profiles of participants with regard to the number of subjects, who answered each question, are presented in Table 1 . Among the 129 cases in this study the prevalence of HBsAg was 3.1%. No statistically significant association was observed between HBsAg positivity and sharing needle equipment, duration of drug use, history of imprisonment, frequency of injection per day, type of drug, tattooing, history of surgery and high risk sexual behaviors, P > 0.05 ( Table 2 ). The highest rate of HBsAg positivity was among cases with more than 10 years duration of drug usage, and history of imprisonment (Table 3) .
Due to the low number of female cases, the statistical analysis of data between different sexes was ignored. Results showed that immunization strategies in DICs targeting IDUs have been instrumental in reducing overall prevalence of HBsAg. Continuous surveillance and repeated studies are needed to monitor trends, and effects of large scale harm reduction intervention.
Discussion
In this study, of 129 IDUs, four subjects were HBsAg positive (3.1%). In Khodadadizade et al. (2005), of 180 subjects five were HBV infected from whom three subjects were IDUs (19 (25) . In another study, in Ahvaz, South-west of Iran, HBsAg prevalence was 3.6% among hospitalized drug users (26) . In Amin-Esmaeili et al. (2012) study on IDUs, in Tehran, the prevalence of past or current HBV infection had a high rate (46.1%), that was mainly correlated with history of imprisonment and drug use of more than 10 years (17) . In some reports from Iran (27) and other countries regarding imprisonment (28, 29) , the frequency (30) and duration of drug injection (28, 31) (36) and Berlin showed similar results, as they concluded that positive history of imprisonment is associated with 1.9 fold and 1.5 fold increase in the risk of HBV seropositivity, respectively. Their studies showed that history of syringe sharing in prison was associated with HBV, HCV and HIV infections. A research done by Nguyen et al. (2006) , estimated the prevalence of HBV among IDUs in Australia to be 2% -3%, in this study long term injection, having been to prison, and injecting in prison were independently associated with HBV infection (37) . There are also reports of greater than 50% prevalence of HBV among IDUs in other countries around the world such as Germany, Georgia and Bulgaria (28, 38, 39 (Table 4) . Low rate of HBsAg positivity in this study might be reflected by HBV vaccination; in this study of 98 subjects, 58.2% had a history of HBV vaccination. The study of Khosravani et al. (2012) (24) , showed a similar low prevalence for HBsAg positivity among high risk groups, same as IDUs in South-west of Iran studied by Khosravani et al. (2012) , where it was concluded that this result may be due to HBV vaccination in that area. It is interesting to note that national levels of 1st (HBV1), 2nd (HBV2) and 3rd (HBV3) dose coverage in Iran have been reported to be 98.9%, 98.8% and 98.4%, respectively (53) . After employment of the HBV vaccination in the Iranian national program of Immunization, and the expanded Program of Immunization (EPI) since 1993, the prevalence of HBV has decreased throughout the country (33, 54) . Another possibility for reduction in prevalence of HBsAg in our study can be due to harm reduction programs that are provided in DICs, since 2005 there have been continuous attempts to raise coverage of harm reduction intervention in Iran (17) . These findings can be a result of the scalingup of harm reduction facilities such as NSP and MMT that started from 2002 and have been expanded since 2005 in Tehran. A considerable number of IDUs are covered under harm-reduction programs, either in DICs or in prison (55) . These results present a good opportunity to receive services for HBV patients to decrease exposure to contaminated blood, as well as risk reduction in high risk behaviors. Drug use is often a hidden behavior in society, and drug users are a kind of hard-to-reach group; therefore, selecting a representative sample of drug users in a geographical area is difficult. Additionally in this study, only IDUs in Tehran were involved, and the results may not be generalized to the entire Iranian IDU population. Due to difficulty in approaching IDUs as a hard-to-reach group,
